Skip to main content
. 2020 Dec 17;59(1):e00951-20. doi: 10.1128/JCM.00951-20

TABLE 1.

Cefiderocol MICs required to inhibit the growth of 90% of Gram-negative bacilli (MIC90)a

Organism(s)b No. of isolates tested MIC (μg/ml)
Range MIC90
Enterobacterales
Escherichia coli 5,139 ≤0.002–8 0.5
        Meropenem not-susceptible E. coli 72 0.015–4 2
    Klebsiella pneumoniae 4,627 ≤0.002–8 1
        Meropenem not-susceptible K. pneumoniae 689 0.004–32 4
    Klebsiella oxytoca 1,434 ≤0.002–4 0.25
        Meropenem not-susceptible K. oxytoca 31 0.03–4 1
    Enterobacter cloacae 1,800 ≤0.002–128 1
    Klebsiella (formerly Enterobacter) aerogenes 1,017 ≤0.002–8 0.5
        Meropenem not-susceptible Enterobacter speciesc 159 0.06–32 8
    Citrobacter freundii complex 931 ≤0.002–8 0.5
    Citrobacter koseri 517 0.008–8 0.5
        Meropenem not-susceptible Citrobacter species 32 0.015–8 2
    Serratia marcescens 2,382 ≤0.002–32 0.5
        Meropenem not-susceptible S. marcescens 38 0.015–4 2
Proteus mirabilis 819 ≤0.002–>256 0.12
Proteus vulgaris 537 ≤0.002–0.5 0.12
Providencia rettgeri 341 ≤0.002–>256 0.12
Morganella morganii 697 ≤0.002–8 0.25
Non-glucose-fermenting Gram-negative bacilli
    Pseudomonas aeruginosa 4,942 ≤0.002–8 0.5
        MDR P. aeruginosa 262 0.002–32 2
    Acinetobacter baumannii 2,896 ≤0.002–>256 2
        MDR A. baumannii 368 0.015–>256 8
    Stenotrophomonas maltophilia 1,173 ≤0.002–64 0.25
        MDR S. maltophilia 218 0.015–>256 0.25
a

Adapted from reference 19.

b

The not-susceptible category includes isolates that tested intermediate and resistant. MDR, multidrug resistant, i.e., resistant to meropenem, amikacin, and ciprofloxacin.

c

Includes Klebsiella aerogenes.